PharmaVOICE 100 Change Agent: Ellen Street, Leading with AuthenticityAugust 02, 2021
ERT executive recognized for accelerating innovation and growth by empowering exceptional employee and customer experiences
PHILADELPHIA – August 3, 2021 – ERT, the global leader in clinical endpoint data collection, announced today that Ellen Street, Executive Vice President, Product and Quality Management, has been named one of 2021’s 100 most inspiring individuals in the life sciences industry by PharmaVOICE. Representing a broad cross-section of industry sectors, PharmaVOICE 100 honorees are nominated by colleagues and selected based on their track record of inspiring others and affecting positive change in their organizations and the industry.
PharmaVOICE recognized Ellen for her authentic leadership approach and her ability to convert challenges to opportunities. She has driven significant improvements in clinical trial technologies and methodologies, enabling more efficient study designs, reduced study timelines and more confidence in trial safety.
“Ellen’s leadership at ERT, which has been integral to ensuring the credibility of clinical trial data with the highest quality of evidence, inspires her teams and colleagues,” said Taren Grom, editor, and co-founder of PharmaVOICE. “Her focus on implementing transformative initiatives and generating innovative ideas and solutions that impact the future of clinical trials and improve worldwide patient health are just some of the reasons why Ellen epitomizes what it takes to be a PharmaVOICE 100.”
Ellen models accountability, collaboration and inclusiveness. She is passionate about challenging cross-functional teams to leverage processes, technologies and new ideas to deliver offerings with value propositions meaningful to customers and patients.
“I love to instill a sense of purpose and desire to go above and beyond,” said Ellen of her leadership style. “I challenge team members to take a broad view and make sure they understand the interdependencies of their decisions.”
In addition to leading her teams, Ellen serves as a mentor at ERT and actively engages in sponsoring the next generation of leaders. She benefits from mutual learning and enjoys observing colleagues take new paths that lead to exciting opportunities and the ability to overcome obstacles and succeed.
To learn more about Ellen’s impact at ERT and the industry at large, read the full feature from this month’s issue of PharmaVOICE.
Clario delivers the leading endpoint technology solutions for clinical trials. Through experience gained from over 19,000 clinical trials delivered in support of 870 regulatory approvals, Clario fuses scientific expertise and global scale into the broadest endpoint technology platform to enable pharmaceutical, biotech and medical device partners to transform lives. Through Trial Anywhere™, Clario has mastered the ability to generate rich evidence across all trial models: decentralized, hybrid and site-based clinical trials. With 30 facilities in nine countries across North America, Europe and Asia Pacific, Clario’s global team of science, technology and operational experts has been delivering the richest clinical evidence for nearly 50 years.